chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I was tested positive for COVID June 28th, which resulted in aggravation of my gastro issues that involved the Opdivo medication. This drug is an auto-immune therapy drug. I'm just recovering from this now.  December 2020 I started having GI issues, and then in May 2021 I was feeling more normal again and I traveled. At the end of June I felt bad, but that is when I tested positive for COVID-19. This included pancreatitis, colitis.
Pain, swelling, redness, pain, sweating and temperature in my upper arm where vaccine was placed. Now unable to raise my hand to my shoulder height, very painful, swollen and unable to sleep.
patient reported 7 days of fatigue, chills, headache that ebbed and flowed over the 7 days after receiving the vaccine
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The patient's pertinent medical history, current conditions and concomitant medications were not reported. On an unknown date the patient was vaccinated with first dose of (Oka/Merck) VARIVAX (dosing details were not reported). On an unknown date the patient experienced chicken pox. The nurse inquired about the administration of second dose of (Oka/Merck) VARIVAX when the patient developed chickenpox at an unspecified time after first dose. The outcome of the event was not reported. The reporter did not provide the causality assessment between the event and the suspect therapy. Additional information has been requested.
Immunizations done 2/11/04. Mother noted erythemic ring around injection site on 2/18/04. Not sure if it was present soon post injection because child dresses himself. The area is 7.5cm widely erythemic ring with 1cm induration center at injection site. Non-tender to pt. No warmth. No exudate. Pt has not had fever, has been well otherwise. 7.5cm erythemic ring was noted on the L lateral thigh.
I woke up with the typical side effects. I had fever, body aches, and chills. I just treated it with Tylenol to keep my fever down. Starting at about noon on the 11th, I started feeling tightness in my chest. It was uncomfortable, but not extremely painful. Throughout the day, those events started happening more frequently and became more uncomfortable. We spoke with my OB and she told us to go to the ER.  We went to the ER at about 8:30pm. They ruled out that it was not a blood clot in my lungs. They noticed a spike in my white blood cells. They gave me an IV with antibiotics. They determined that a certain level in my labs was increasing at a concerning scale. It basically doubled or tripled in a matter of hours. The fever made the chest pains worse.I was dealing with fever, body aches, and increasing discomfort. I had chest pressure and pain. That lasted through the 11th. Finally on the 13th, it started to resolve. The fever started going down and the chest pain was going away. It started getting under control. The baby was fine through everything. I suffered through viral parotitis (inflammation of the heart). As of yesterday, my Petronian levels were still going down and they were in the 80s. I was discharged yesterday evening and my levels are still going down. I am due October 29th. I was 33 weeks pregnant.
Upper shoulder where Dtap given: rash, very red and hot, painful. Next day (Sat) swollen and puffy, at night had temp of 100.2. On Sunday, Arm continued to hurt had patchy red rash, was hot. Did call MD for advice, told to watch and take the meds.  Took ibuprofen and Benadryl.  By Sunday night she was much better and Monday she was OK.
Systemic: Joint Pain-Severe, Systemic: Vomiting-Severe, Additional Details: Had pain in his knee a week after the shot, so sharp and severe that it put him off balance and made him throw up. Pain lasted about a week, even with ibuprofen.
Since 12 December she has complained of recurrent episodes of generalized itching and rashes described as raised, red, itchy whelts which can occur anywhere on her body, especially at sites of pressure or where his skin is scraped or scratched. Lesions last less than 24 hours, affect her palms and soles, and resolve without post-inflammatory changes. She denies laryngeal, pulmonary, GI, neurologic, and cardiovascular symptoms with these episodes. Episodes also associated with stress but not associated with heat, exercise, sweating, cold, foods, medications, NSAIDs, IV contrast, latex exposure, known infections, or insect bites/stings. She received her Moderna COVID-19 vaccine booster dose on 2 December, 10 days prior to onset of symptoms. He has used oral antihistamines with some benefit. She denies constitutional symptoms. UCT score today is 30 (3, 4, 3, 4, 4, 4, 4, 4). No history of adverse reactions to prior vaccines.
stomach pain, weight loss, urinating often, no treatment until wed. jan 20th 2010.
Fever, 90+ hours of crying, cessation of eating, voiding, going limp, sporadic breathing.
Arm pain started within 2 hours of receiving injection. Same side neck pain started within 4 hours. Neck stiffness was noted within 8 hours. Within 12 hours, all-over body aches and non-fever related chills began. These persisted for 24 hours. Injection site was visibly swollen by hour 48. This last symptom dissipated within the week post injection.  The body aches and chills were temporarily relieved with the use of acetaminophen; multiple doses were required.
the day after immunization the patient developed welts all over her body that itch extremely bad. benadryl provided minimal relief. reported on day 4 of welts. patient is going to follow up with primary care when they open after the weekend ends and has been instructed if they have any shortness of breath or throat tightness to go straight to the ER.
Janssen COVID-19 vaccine EUA:  Hives with associated itching and burning, hypertension  Treated with IM Solu-Medrol and Benadryl, sent home on Prednisone taper
Swelling and itching of the face, face became beet red; itching in the groin area. This lasted for 8 days, then the face became splotchy and itchy at different times of the day and a rash appeared on the right arm, across the abdomen, and right thigh.
Extreme skin sensitivity lasting 24 hours. Persistent joint pain in the hips lasting 24 hours. Treated with Ibuprofen and Naproxen Sodium unsuccessfully.
Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 18-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 18-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications was provided by the reporter.  No treatment was provided by the reporter.  Vaccine was administered on Deltoid.   This case was linked to MOD-2021-361706 (Patient Link).
Patient received both doses of Moderna covid19 vaccine (on 1/6/2021 and 2/3/2021) subsequently tested positive for covid19 on 3/23/2021 but was asymptomatic.
Pfizer Covid 19 vaccine for 5-11 yrs  was administered after being stored in the refrigerator more than 10 weeks
Information has been received from a physician concerning a female who on 23-DEC-2009 was vaccinated PO with the 2 ml first dose of ROTATEQ. On 03-MAR-2010 the patient was vaccinated PO with the second 2 ml dose of ROTATEQ (lot number___). The physician reported that the patient vomited up the first and second dose of vaccine. It was unknown if medical attention was sought. The outcome of the patient was not reported. Additional information has been requested.
I got sick; Red; Upper arm is still warm; Itches like crazy; High fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (I got sick), ERYTHEMA (Red), FEELING HOT (Upper arm is still warm), PRURITUS (Itches like crazy) and PYREXIA (High fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 24-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (I got sick), ERYTHEMA (Red), FEELING HOT (Upper arm is still warm), PRURITUS (Itches like crazy) and PYREXIA (High fever). At the time of the report, ILLNESS (I got sick) and PYREXIA (High fever) had resolved and ERYTHEMA (Red), FEELING HOT (Upper arm is still warm) and PRURITUS (Itches like crazy) had not resolved.            Concomitant product use was not provided. Treatment information was not provided.
got sick; Initial information was received on 24-Oct-2020 regarding an unsolicited valid non-serious case received from a consumer (patient) via social media.  This case involves a patient of unknown age and gender who got sick (illness), while he/she received vaccine INFLUENZA VACCINE.  The patient's past vaccination(s) included Influenza vaccine as prophylactic vaccination. The patient's medical history, past medical treatment(s), concomitant therapy and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious sick (illness) (Unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data were not reported.   It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was unknown.  There will be no information available on batch number for this case.
Swelling from elbow to top of arm. Area red, hard and painful. Felt ill!. 11/14/14 red but pt feels better.
Admission date 8/10/21. Had both doses of Pfizer vaccine, the last one on 3/11/21. Was diagnosed with COVID infection 10 days prior at outside clinic. Presents now with SOB, weakness, fatigue and cough. Treated with antibiotics and Remdesivir. Discharged on 8/12/21.
PT RECD FIRST DOSE OF PFIZER 2/8/21, RECD 2ND DOSE OF PFIZER WITH OTHENA ON 4/25/21. VACCINE POD. OTHENA REGISTERED PT AS A FIRST DOSE THEN SCHEDULED HER FOR ANOTHER DOSE ON 5/16. PT RECD ANOTHER PFIZER VACCINE ON 5/16 AND THEN TELLING THE RN ABOUT HER 3RD DOSE.
This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 29-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 62-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis. No Medical History information was reported. On 29-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 29-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 29-Jul-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 29-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 day by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 29-Jul-2022). No concomitant product use was reported. Reportedly, Patient received half dose. Vial did not undergo any temperature excursions. The vial was initially stored in the refrigerator on 4Jun2022. No treatment information was provided.
expired VAQTA vaccine used; This spontaneous report has been received from a health care professional regarding to a 34-year-old patient. The patient's concurrent conditions, medical history, concomitant therapies, drug allergies or reaction were not provided.   On 16-NOV-2020, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) 1 mL (anatomical location of vaccine and route of administration were not reported), lot # S025258, expiration date reported 05-NOV-2020, for prophylaxis.    combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S025258; expirationdate: 05-NOV-2020; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
"COVID arm"-- a minor allergic reaction a few days after the vaccination. Itchiness, redness, hardness under the skin. No pain for me, though. Itchiness is difficult to ignore, but I could if I felt like it. Redness is visible, but not to an alarming degree. Hardness is compatible to a mosquito bite that has been scratched enough to become very irritated and large, and is a circular patch  about 1-2 inches in diameter. I've had it for about a day or two so far, and it's getting itchier, but still no pain now that the initial injection soreness is gone.
very sore arm at injection site; very large/swollen lymph node; ache in my right breast/armpit; ache in my right breast/armpit; body aches; My limbs felt so heavy I wasn't able to lift them off the bed; Lethargy; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (Lethargy), AXILLARY PAIN (ache in my right breast/armpit), LIMB DISCOMFORT (My limbs felt so heavy I wasn't able to lift them off the bed), BREAST PAIN (ache in my right breast/armpit) and MYALGIA (body aches) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001C21A and 039A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.  The patient's past medical history included Anemia (Border line iron deficiency anemia.) in 2017. Concomitant products included IRON EXTRA for Iron deficiency, COLECALCIFEROL, FISH OIL (FISH OIL PLUS VITAMIN D) for an unknown indication.  On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021 at 11:20 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-May-2021, the patient experienced AXILLARY PAIN (ache in my right breast/armpit), BREAST PAIN (ache in my right breast/armpit) and LYMPHADENOPATHY (very large/swollen lymph node). On an unknown date, the patient experienced LETHARGY (Lethargy), LIMB DISCOMFORT (My limbs felt so heavy I wasn't able to lift them off the bed), MYALGIA (body aches) and INJECTION SITE PAIN (very sore arm at injection site). At the time of the report, LETHARGY (Lethargy), LIMB DISCOMFORT (My limbs felt so heavy I wasn't able to lift them off the bed) and MYALGIA (body aches) had resolved, AXILLARY PAIN (ache in my right breast/armpit), BREAST PAIN (ache in my right breast/armpit) and LYMPHADENOPATHY (very large/swollen lymph node) had not resolved and INJECTION SITE PAIN (very sore arm at injection site) outcome was unknown.     The other concomitants include Thyroid PX for hypothyroidism from 2017, DIMension 3 for estrogen metabolism from 2017, RegeneMax Plus for collagen generator from 2019 taken daily by oral route. No treatment was reported.  This case was linked to US-MODERNATX, INC.-MOD-2021-078457 (E2B Linked Report). This case was linked to MOD-2021-078457 (Patient Link).; Sender's Comments: US-MODERNATX, INC.-MOD-2021-078457:Dose 1
Vaccination was a seasonal Quad Influenza Vaccine: Pharmacy. Adverse event: Dizziness/Vertigo. Two neurologists, three doctors and an ENT all felt it was a virus. Physicians were a Dr except for DO seen at: neurology clinic. In February 2018 started seeing different Dr another location.
improperly stored PEDVAX was administered to the patient on an unknown date; no adverse effect; This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. Pertinent medical history, drug reactions, allergies and concomitant medications were not reported.  On an unknown date, the patient was vaccinated with an improperly stored dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (lot number: N024570, expiration date: 01-MAY-2020) (dose and route of administration were not provided). The vaccine was stored in temperature below 36 degrees Fahrenheit (32.1 degrees Fahrenheit) for 8 hours. There was no previous temperature excursion. Digital data lodger was involved. No adverse effects were reported.
expired vaccine is stored and then administered; 606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (expired vaccine is stored and then administered) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (expired vaccine is stored and then administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (expired vaccine is stored and then administered) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were provided. It was reported that the vial was initially stored in the refrigerator on 04-Nov-2021. Patient did not experienced any adverse event. Vial does not undergo temperature excursions. No treatment medications were provided.
Pt came in for swelling and redness form a Td injection on her left deltoid she received on 7-11-2007. It was red and very sore to the touch. Ptdid not have any fever. She was treated with an antibotic Bactrim  DS and to apply cool comopress to affected area and we will see the pt back at our office on 7-18-2007.
Case number PHEH2014US019158, is an initial spontaneous report received from a nurse on 19 Sep 2014. This report refers to a 29-year-old female patient. Past medical history and concomitant medication was not reported. On 18 Sep 2014, the patient was inadvertently vaccinated with FLUVIRIN (batch number: 1412001) intramuscularly at a dose of 1.0 ml instead of the recommended 0.5 ml dose. No adverse event was reported following this medication error (overdose).
i'm now sick with all the symptoms of covid; coughing is getting worse; I feel awful; With all the symptoms of covid; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (i'm now sick with all the symptoms of covid), COUGH (coughing is getting worse), FEELING ABNORMAL (I feel awful) and SUSPECTED COVID-19 (With all the symptoms of covid) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (i'm now sick with all the symptoms of covid), COUGH (coughing is getting worse), FEELING ABNORMAL (I feel awful) and SUSPECTED COVID-19 (With all the symptoms of covid). At the time of the report, ILLNESS (i'm now sick with all the symptoms of covid), COUGH (coughing is getting worse), FEELING ABNORMAL (I feel awful) and SUSPECTED COVID-19 (With all the symptoms of covid) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication information was reported No treatment medication information was reported
Pt recv vax on 11/20/97; approx 5 wk post vax pt developed asthma
pt recv vax & devel chills, fever 2-3 days p/vax;
pain; heat at injection site, mostly when exercising; This case was reported by a physician via call center representative and described the occurrence of injection site pain in a 17-year-old female patient who received Men B NVS (Bexsero) (batch number ABX797AB, expiry date 29th February 2020) for prophylaxis.   On 7th January 2020, the patient received the 1st dose of Bexsero. On an unknown date, less than a month after receiving Bexsero, the patient experienced injection site pain and injection site warmth. On an unknown date, the outcome of the injection site pain and injection site warmth were recovered/resolved.   It was unknown if the reporter considered the injection site pain and injection site warmth to be related to Bexsero.  Additional details were provided as follows: The patient received Bexsero and had pain and heat at injection site, mostly when exercising.  The event has resolved. The reporter consented to follow up.
ADMINISTRATION OF EXPIRED VACCINE; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 201A21A, and expiry: 21-SEP-2021) dose was not reported, administered on 22-SEP-2021 for prophylactic vaccination. No concomitant medications were reported.  On 22-SEP-2021, the patient experienced administration of expired vaccine. The action taken with covid-19 vaccine was not applicable. The outcome of administration of expired vaccine was not reported. This report was non-serious.
MMR given 09/14/2001 for negative titer (measles). Pt to employee services 09/17/2001 with complaint of N/V and URI symptoms. Seen in ER 09/19/2001 and dx pregnant (LMP 7101) states she didn't read consent. Follow up with OBGYN. Dr on 09/20/2001 is testing pt for fetal defects. OV to ES 09/24/2001 on medical leave, N and V abdominal cramps continue. Referred back to Dr.